reducing chemotherapy in dlbcl: flyer results
Published 5 years ago • 193 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
0:43
reducing chemotherapy-induced adverse events in patients with aml
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:15
the advantage of early blinatumomab treatment over chemotherapy in all
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
4:23
the changing role of chemotherapy in the treatment of various subtypes of nhl
-
14:59
managing side effects
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
1:53
latest updates in car-t therapy for follicular lymphoma
-
1:38
future of aggressive lymphoma treatment: a shift towards chemo-free regimens
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:24
treatment of bulky stage i/ii lymphoma
-
0:45
difference between quality of life & patient-reported outcomes
-
2:39
reduction of chemotherapy cycles for diffuse large b-cell lymphoma
-
3:27
why we need novel strategies for diffuse large b-cell lymphoma
-
5:02
treatment of lymphoma: overview of the continued progress
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
5:40
developments in b-cell lymphoma management
-
1:15
personalized medicine for dlbcl
-
2:56
moving towards chemotherapy-free approaches in r/r follicular lymphoma